COMPARE · Data as of August 21, 2026
AHR vs CTRE
Verdict: Side-by-side breakdown using the Bull Rankings model. AHR scored 78.0, CTRE scored 81.0 — CTRE leads.
Compare another set
AHR
American Healthcare REIT, Inc.
43.3Fin
$55.93 · $12.2B
fundamentals as of
Strength gap
25.5
CTRE leads
CTRE
CareTrust REIT, Inc.
68.8Fin
$39.58 · $9.4B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- Fastest growthCTRE+61.8%
- Strongest balance sheetAHR0.42
Side by side · every name on one set of axes
Fundamentals, head-to-head
AHR
CTRE
1.8%C+
Yield
3.9%B+
+9.1%B
Rev
+61.8%A
0.42A
D/E
0.72B+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
AHRAmerican Healthcare REIT, Inc.
Why now
REIT - Healthcare Facilities · market cap $12.2b. 5% off the 52-week high of $58.70. 15 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $63.67 (implying +14% upside).
Moat
Moat signals from the quantitative card are modest — profitability and capital efficiency are middle-of-pack. The thesis here depends on softer factors (switching costs, brand, distribution, regulatory protection) not captured by the quality-growth screen.
Risk
Net margin 4.8% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first. ROE 4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
CTRECareTrust REIT, Inc.
Why now
REIT - Healthcare Facilities · market cap $9.4b. 9% off the 52-week high of $43.62. Revenue growing +62% — in hypergrowth territory. 13 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $45.38 (implying +15% upside).
Moat
Net margin 62% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma.
Risk
P/S 16.4x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.